Asthma

Asthma Drug Pipeline Analysis and Market Forecasts to 2016

Summary

GlobalData, the industry analysis specialist's new report, ""Asthma - Drug Pipeline Analysis and Market Forecasts to 2016"" is an essential source of information and analysis on the global asthma market. The report identifies the key trends shaping and driving the global asthma market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global asthma sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData's team of industry experts.

Scope

The scope of the report includes:

• Annualized global asthma market revenues data from 2000 to 2008, forecast forward for 7 years to 2015.
• Geographic markets covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.
• Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends.
• Analysis of the current and future market competition in the global asthma market.
• Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
• Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with asthma.

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:

• Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the global asthma market.
• Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global asthma market in future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
• What's the next big thing in the global asthma market landscape? - Identify, understand and capitalize.

• 1 Asthma Market: Executive Summary
• 2 Table of Contents
  • 2.1 List of Tables
  • 2.2 List of Figures
• 3 Asthma Market: Market Characterization
  • 3.1 Overview
  • 3.2 Asthma Market Size
  • 3.3 Asthma Market Forecast and CAGR
  • 3.4 Drivers and Barriers for Asthma Market
    • 3.4.1 Drivers for Asthma Market
    • 3.4.2 Barriers for Asthma Market
  • 3.5 Opportunity and Unmet Need
  • 3.6 Key Takeaway
• 4 Asthma Market: Competitive Assessment
  • 4.1 Overview
  • 4.2 Strategic Competitor Assessment
  • 4.3 Product Profiles of the Major Marketed Products
    • 4.3.1 Overview
    • 4.3.2 Efficacy
    • 4.3.3 Safety Profile
    • 4.3.4 Pricing
    • 4.3.5 Clinical Study Details
  • 4.4 Key Takeaway
• 5 Asthma Market: Pipeline Assessment
  • 5.1 Overview
  • 5.2 Strategic Pipeline Assessment
    • 5.2.1 Technology Trends Analytical Framework
  • 5.3 Asthma Therapeutics - Promising Drugs under Clinical Development
  • 5.4 Molecule Profiles of Promising Drugs under Clinical Development
    • 5.4.1. Overview
    • 5.4.2 Efficacy
    • 5.4.3 Safety
    • 5.4.4 Clinical Study Details
  • 5.5 Asthma Therapeutics Market - Clinical Pipeline by Mechanism of Action
  • 5.6 Asthma Pipeline - Pipeline by Clinical Phases of Development
    • 5.6.1 Asthma Therapeutics - Phase III Clinical Pipeline
    • 5.6.2 Asthma Therapeutics - Phase II Clinical Pipeline
    • 5.6.3 Asthma Therapeutics - Phase I Clinical Pipeline
    • 5.6.4 Asthma Therapeutics - Preclinical Pipeline
    • 5.6.5 Asthma Therapeutics - Discovery Pipeline
  • 5.7 Discontinued / Suspended Drugs for Asthma
  • 5.8 Key Takeaway
• 6 Asthma Market: Implications for Future Market Competition
• 7 Asthma Market: Future Players in Asthma Market
• 8 Asthma Market: Appendix
  • 8.1 Definitions
  • 8.2 Acronyms
  • 8.3 Research Methodology
    • 8.3.1 Coverage
    • 8.3.2 Secondary Research
    • 8.3.3 Forecasting
      • 8.3.3.1 Epidemiology-based Forecasting
    • 8.3.4 Primary Research
    • 8.3.5 Expert Panel validation
  • 8.4 Contact Us
  • 8.5 Disclaimer
  • 8.6 Sources
• List of Tables
  • Table 1: Global Asthma Treatment by Stage of the Disease, 2009
  • Table 2: Global Asthma Therapeutics Market, Revenue Forecasts ($ m), 2001-2009
  • Table 3: Global Asthma Therapeutics Market, Revenue Forecasts ($ m), 2009-2016
  • Table 4: Major marketed products comparison in Asthma, 2009
  • Table 5: Asthma Therapeutics - Most Promising Drugs Under Clinical Development, 2009
  • Table 6: Asthma Therapeutics - Phase III Clinical Pipeline, 2009
  • Table 7: Asthma Therapeutics - Phase II Clinical Pipeline, 2009
  • Table 8: Asthma Therapeutics - Phase I Clinical Pipeline, 2009
  • Table 9: Asthma Therapeutics - Preclinical Pipeline, 2009
  • Table 10: Asthma Therapeutics - Drug Discovery Pipeline, 2009
  • Table 11: Asthma Therapeutics - List of Discontinued Drugs, 2009
• List of Figures
  • Figure 1: Global Asthma Therapeutics Market Forecast, 2000-2015
  • Figure 2: Asthma Therapeutics Market - Opportunity and Unmet Need, 2009
  • Figure 3: Asthma Therapeutics Market - Strategic Competitor Assessment, 2009
  • Figure 4: Technology Trends Analytic Framework of the Asthma Pipeline, 2009
  • Figure 5: Technology Trends Analytic Framework of the Asthma Pipeline - Description, 2009
  • Figure 6: Asthma Therapeutics Market - Clinical Pipeline by Mechanism of Action, 2009
  • Figure 7: Asthma Pipeline by Phase of Clinical Development, 2009
  • Figure 8: Asthma Therapeutics Market - Strategic Competitor Assessment, 2009
  • Figure 9: Asthma Therapeutics Market - Clinical Pipeline by Company, 2009
  • Figure 10: GlobalData Methodology
  • Figure 11: GlobalData Market Forecasting Model